Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells

Nucleic Acids Res. 1988 Mar 25;16(5):1903-19. doi: 10.1093/nar/16.5.1903.

Abstract

The estrogen-induced 52K protein secreted by human breast cancer cells is a lysosomal protease recently identified as a pro-cathepsin D by sequencing several cDNA clones isolated from MCF7 cells (Augereau et al., Mol. Endocr.). Using one of these clones, we detected, in MCF7 cells, a 2.2 kb mRNA whose level was rapidly increased 4- to 10-fold by estradiol, but not by other classes of steroids. Other mitogens, such as epidermal growth factor and insulin, also induced the 2.2 kb mRNA in a dose-dependent manner. Induction with epidermal growth factor was as rapid but was 2- to 3-fold lower than with estradiol. Antiestrogens had no effect on the 52K-cathepsin-D mRNA in MCF7 cells, but became estrogen agonists in two antiestrogen-resistant sublines R27 and LY2. The use of transcription and translation inhibitors and nuclear run-on experiments indicate that estradiol enhances transcription of the 52K-cathepsin-D gene in MCF7 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / enzymology
  • Breast Neoplasms / genetics*
  • Cathepsin D / genetics*
  • Cell Nucleus / metabolism
  • Epidermal Growth Factor / pharmacology
  • Estradiol / pharmacology*
  • Gene Expression Regulation
  • Growth Substances / pharmacology*
  • Humans
  • Insulin / pharmacology
  • Steroids / pharmacology
  • Tamoxifen / pharmacology
  • Time Factors
  • Transcription, Genetic / drug effects
  • Tumor Cells, Cultured

Substances

  • Growth Substances
  • Insulin
  • Steroids
  • Tamoxifen
  • Estradiol
  • Epidermal Growth Factor
  • Cathepsin D